We analyzed also the activity of caspase-3 in lung cancer cells treated with RESV to check whether proliferation inhibition of lung cancer cells was a result of caspase-3-dependent cell death and to see if the ability of RESV to induce caspase activity was similar or not in tested lung cancer cells. Here, CASP3 is linked to lung carcinoma.